• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用可穿戴数据的新冠肺炎实时警报系统

Real-time Alerting System for COVID-19 Using Wearable Data.

作者信息

Alavi Arash, Bogu Gireesh K, Wang Meng, Rangan Ekanath Srihari, Brooks Andrew W, Wang Qiwen, Higgs Emily, Celli Alessandra, Mishra Tejaswini, Metwally Ahmed A, Cha Kexin, Knowles Peter, Alavi Amir A, Bhasin Rajat, Panchamukhi Shrinivas, Celis Diego, Aditya Tagore, Honkala Alexander, Rolnik Benjamin, Hunting Erika, Dagan-Rosenfeld Orit, Chauhan Arshdeep, Li Jessi W, Li Xiao, Bahmani Amir, Snyder Michael P

机构信息

Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.

Department of Computer Science, Stanford University, Stanford, CA, USA.

出版信息

medRxiv. 2021 Jun 21:2021.06.13.21258795. doi: 10.1101/2021.06.13.21258795.

DOI:10.1101/2021.06.13.21258795
PMID:34189532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8240687/
Abstract

Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, and pre-symptomatic signals were observed a median of three days prior to symptom onset. Furthermore, by examining over 100,000 survey annotations, we found that other respiratory infections as well as events not associated with COVID-19 (e.g. stress, alcohol consumption, travel) could trigger alerts, albeit at a lower mean period (1.9 days) than those observed in the COVID-19 cases (4.3 days). Thus this system has potential both for advanced warning of COVID-19 as well as a general system for measuring health via detection of physiological shifts from personal baselines. The system is open-source and scalable to millions of users, offering a personal health monitoring system that can operate in real time on a global scale.

摘要

传染病的早期检测对于减少传播和促进早期干预至关重要。我们构建了一个基于智能手表的实时警报系统,用于检测个体层面与早期感染发作相关的异常生理和活动信号(如静息心率、步数)。将该系统应用于3246名参与者的队列中时,我们发现78%的病例针对症状前和无症状的COVID-19感染生成了警报,症状前信号在症状发作前的中位时间为三天。此外,通过检查超过10万条调查注释,我们发现其他呼吸道感染以及与COVID-19无关的事件(如压力、饮酒、旅行)也可能触发警报,尽管其平均时间(1.9天)比COVID-19病例中观察到的时间(4.3天)短。因此,该系统既具有COVID-19提前预警的潜力,也具有通过检测个人基线生理变化来衡量健康状况的通用系统的潜力。该系统是开源的,可扩展至数百万用户,提供了一个能够在全球范围内实时运行的个人健康监测系统。

相似文献

1
Real-time Alerting System for COVID-19 Using Wearable Data.使用可穿戴数据的新冠肺炎实时警报系统
medRxiv. 2021 Jun 21:2021.06.13.21258795. doi: 10.1101/2021.06.13.21258795.
2
Real-time alerting system for COVID-19 and other stress events using wearable data.利用可穿戴设备数据实现 COVID-19 和其他压力事件的实时预警系统。
Nat Med. 2022 Jan;28(1):175-184. doi: 10.1038/s41591-021-01593-2. Epub 2021 Nov 29.
3
Detection of Common Respiratory Infections, Including COVID-19, Using Consumer Wearable Devices in Health Care Workers: Prospective Model Validation Study.在医护人员中使用消费级可穿戴设备检测包括新冠病毒病在内的常见呼吸道感染:前瞻性模型验证研究
JMIR Form Res. 2024 Jul 17;8:e53716. doi: 10.2196/53716.
4
Pre-symptomatic detection of COVID-19 from smartwatch data.从智能手表数据中进行 COVID-19 的症状前检测。
Nat Biomed Eng. 2020 Dec;4(12):1208-1220. doi: 10.1038/s41551-020-00640-6. Epub 2020 Nov 18.
5
Early Detection of Symptom Exacerbation in Patients With SARS-CoV-2 Infection Using the Fitbit Charge 3 (DEXTERITY): Pilot Evaluation.使用Fitbit Charge 3(DEXTERITY)早期检测新型冠状病毒2型感染患者的症状加重:初步评估。
JMIR Form Res. 2021 Sep 16;5(9):e30819. doi: 10.2196/30819.
6
Sensor-based surveillance for digitising real-time COVID-19 tracking in the USA (DETECT): a multivariable, population-based, modelling study.基于传感器的监测对美国实时 COVID-19 追踪的数字化应用(DETECT):一项多变量、基于人群、建模研究。
Lancet Digit Health. 2022 Nov;4(11):e777-e786. doi: 10.1016/S2589-7500(22)00156-X. Epub 2022 Sep 22.
7
Opportune warning of COVID-19 in a Mexican health care worker cohort: Discrete beta distribution entropy of smartwatch physiological records.墨西哥医护人员队列中对COVID-19的适时预警:智能手表生理记录的离散贝塔分布熵
Biomed Signal Process Control. 2023 Jul;84:104975. doi: 10.1016/j.bspc.2023.104975. Epub 2023 Apr 21.
8
Characterizing COVID-19 and Influenza Illnesses in the Real World via Person-Generated Health Data.通过个人生成的健康数据在现实世界中对新冠病毒病和流感疾病进行特征描述。
Patterns (N Y). 2020 Dec 13;2(1):100188. doi: 10.1016/j.patter.2020.100188. eCollection 2021 Jan 8.
9
10
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.

本文引用的文献

1
Wearable Sensors for COVID-19: A Call to Action to Harness Our Digital Infrastructure for Remote Patient Monitoring and Virtual Assessments.用于新冠疫情的可穿戴传感器:呼吁利用我们的数字基础设施进行远程患者监测和虚拟评估。
Front Digit Health. 2020 Jun 23;2:8. doi: 10.3389/fdgth.2020.00008. eCollection 2020.
2
Wearable sensors enable personalized predictions of clinical laboratory measurements.可穿戴传感器可实现临床实验室测量的个性化预测。
Nat Med. 2021 Jun;27(6):1105-1112. doi: 10.1038/s41591-021-01339-0. Epub 2021 May 24.
3
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
Pre-symptomatic detection of COVID-19 from smartwatch data.从智能手表数据中进行 COVID-19 的症状前检测。
Nat Biomed Eng. 2020 Dec;4(12):1208-1220. doi: 10.1038/s41551-020-00640-6. Epub 2020 Nov 18.
6
Wearable sensor data and self-reported symptoms for COVID-19 detection.可穿戴传感器数据和自我报告症状用于 COVID-19 检测。
Nat Med. 2021 Jan;27(1):73-77. doi: 10.1038/s41591-020-1123-x. Epub 2020 Oct 29.
7
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries.24410 名新型冠状病毒(SARS-CoV-2;COVID-19)感染者的症状流行率:来自 9 个国家的 148 项研究的系统评价和荟萃分析。
PLoS One. 2020 Jun 23;15(6):e0234765. doi: 10.1371/journal.pone.0234765. eCollection 2020.
8
Interpreting a covid-19 test result.解读新冠病毒检测结果。
BMJ. 2020 May 12;369:m1808. doi: 10.1136/bmj.m1808.
9
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎(COVID-19)患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
10
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection.新型冠状病毒感染中病毒清除的时间动力学及症状消退情况
Am J Respir Crit Care Med. 2020 May 1;201(9):1150-1152. doi: 10.1164/rccm.202003-0524LE.